pre-IPO PHARMA

COMPANY OVERVIEW

Chrono Therapeutics is a pharmaceutical company with a vision of transforming disease and addiction management to become the market leader in programmable passive transdermal drug delivery (TDD) coupled with real-time behavioral support. Chrono’s executive leadership combines years of professional experience and personal passions for developing life-saving medical products.


LOCATION

  • Hayward, CA, USA
  • Seattle, WA, USA

  • THERAPEUTIC AREAS

  • Neurological Disorders

  • WEBSITE

    https://chronothera.com/


    CAREER WEBSITE

    https://chronothera.com/careers/


    SOCIAL MEDIA


    INVESTORS

    5am-ventures asahi-kasei canaan-partners cota-capital emergent-medical-partners endeavour-vision fountain-healthcare-partners general-electric-ventures hikma-ventures kaiser-permanente-ventures mayo-clinic-ventures mission-bay-capital rock-health xeraya-capital


    PRESS RELEASES


    Feb 1, 2018

    Chrono Therapeutics Announces Appointment of David Happel as Chief Executive Officer


    Sep 8, 2016

    Chrono Therapeutics Raises $47.6 Million in Series B Financing to Advance its Clinical Platform for Personalized Drug Therapy


    Mar 4, 2016

    Chrono Therapeutics' Smoking Cessation Technology Demonstrates Significant Reduction in Nicotine Cravings


    Aug 25, 2015

    Chrono Therapeutics Receives Second Fast Track SBIR Grant from National Cancer Institute for Patient-individualized Smoking Cessation Therapy


    Mar 3, 2015

    Chrono Therapeutics Receives Investment from Rock Health to Advance SmartStopTM Smoking Cessation Technology


    For More Press Releases


    Google Analytics Alternative